<DOC>
	<DOCNO>NCT00273858</DOCNO>
	<brief_summary>This Phase 4 open label , non-interventional , multi-center study evaluate safety Enbrel ( etanercept ) treatment patient receive etanercept 25mg sc twice weekly 50mg etanercept weekly . The improvement health-related quality life also evaluate .</brief_summary>
	<brief_title>Study Evaluating Safety Etanercept Rheumatoid Arthritis , Ankylosing Spondylitis Psoriatic Arthritis</brief_title>
	<detailed_description>Patients already prescribe receive etanercept first time treatment Rheumatoid Arthritis , Ankylosing Spondylitis Psoriatic Arthritis accord Summary Product Characteristics ( SmPC ) . Patients recruit sequentially base eligibility criterion number limit assign site .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>18 year age old time consent Satisfies 1987 ACR Revised Criteria Rheumatoid Arthritis diagnosis ankylose spondylitis psoriatic arthritis , determine doctor Provides inform consent Demonstrate negative serum urine pregnancy test prior administration etanercept . Sexually active woman participate study must use medically acceptable form contraception . Patients already prescribe etanercept accord approve labelling Has hypersensitivity etanercept Has sepsis risk sepsis . Treatment etanercept initiated patient active infection ( ie . hepatitis C , hepatitis B , active TBC ) Is pregnant breastfeeding Has significant concurrent medical disease include , uncompensated congestive heart failure , myocardial infarction within 12 month , unstable angina pectoris , history human immunodeficiency virus ( HIV ) infection , immunodeficiency syndrome , central nervous system ( CNS ) demyelinate event suggestive multiple sclerosis Has history confirm blood dyscrasia Received live ( attenuate ) vaccine within 4 week screen visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>Psoriatic Arthritis</keyword>
</DOC>